Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DB25FZC86
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,623
Award facts
- Contract value 100% obligated
- $8,622.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count). This firm fixed-price delivery order, valued at $8,622.72, was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025. The delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open market despite its small business status. The place of performance is Park Ridge, Illinois, where the company maintains its primary operations.
This award represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products to support medical supply needs across Department of Defense healthcare facilities worldwide. Xtandi, an oncology treatment, is among the specialty pharmaceutical products covered under this master contract. As a consistent supplier to the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established itself as a critical provider of prescription medications, biologics, and medical consumables to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FZC86?
SPE2DB25FZC86 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FZC86 worth?
The government has obligated $8,623 on SPE2DB25FZC86.
Is contract SPE2DB25FZC86 an order under another contract?
Yes. SPE2DB25FZC86 is a delivery order under SPE2DB22D9143, an indefinite delivery contract.
Was contract SPE2DB25FZC86 competed?
The extent of competition for SPE2DB25FZC86 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award